Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Panoussaki, A."'
Autor:
Skarlos, D.V. *, Samantas, E., Briassoulis, E., Panoussaki, E., Pavlidis, N., Kalofonos, H.P., Kardamakis, D., Tsiakopoulos, E., Kosmidis, P., Tsavdaridis, D., Tzitzikas, J., Tsekeris, P., Kouvatseas, G., Zamboglou, N., Fountzilas, G.
Publikováno v:
In Annals of Oncology September 2001 12(9):1231-1238
Autor:
G. Georgakopoulos, N. Throuvalas, A. Kouveli, D. Antonadou, M. Paraskevaidis, N. Coliarakis, P. Karageorgis, G. Sarris, E. Athanassiou, M. Sinodinou, A. Panoussaki
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 56:1154-1160
To evaluate whether pretreatment with amifostine can reduce treatment-induced toxicity in patients with pelvic malignancies undergoing radiotherapy (RT).A total of 205 patients with pelvic malignancies (rectal, 32; bladder, 47; prostate, 40; gynecolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d031413bb1aad6dfd08c897eba394762
https://doi.org/10.1016/s0360-3016(03)00187-1
https://doi.org/10.1016/s0360-3016(03)00187-1
Autor:
M. Synodinou, D. Antonadou, Grigoris Georgakopoulos, P. Karageorgis, N. Throuvalas, N. Coliarakis, Katerina Panoussaki, H. Athanassiou, C. Verigos, Athina Kouveli
Publikováno v:
International journal of radiation oncology, biology, physics. 51(4)
This multicenter trial investigated whether daily pretreatment with amifostine (A) could reduce the incidence of acute and late lung toxicity and esophagitis without affecting antitumor efficacy of radiation in advanced lung cancer.Radiotherapy (XRT)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d8500eac4ae38014c58a0b809e463af
https://pubmed.ncbi.nlm.nih.gov/12128148
https://pubmed.ncbi.nlm.nih.gov/12128148
Autor:
Skarlos, Dimosthenis V., Samantas, E., Briassoulis, E. Ch, Panoussaki, E., Pavlidis, Nicholas, Kalofonos, H. P., Kardamakis, D., Tsiakopoulos, E., Kosmidis, Paraskevas A., Tsavdaridis, D., Tzitzikas, J., Tsekeris, P., Kouvatseas, G., Zamboglou, N., Fountzilas, George
Publikováno v:
Annals of Oncology
Background: Concurrent platinum-etoposide chemotherapy given in combination with hyperfractionated thoracic radiation therapy (HTRT) in limited disease (LD) small cell lung cancer (SCLC) is associated with a high response rate and significant prolong
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d07a5a9e6baaa33a5a25b5e3f95bd0e9
http://olympias.lib.uoi.gr/jspui/handle/123456789/17274
http://olympias.lib.uoi.gr/jspui/handle/123456789/17274
Autor:
Skarlos, Dimosthenis V., Samantas, E., Pectasides, Dimitrios, Pavlidis, Nicholas, Kalofonos, H. P., Klouvas, G. D., Panoussaki, E., Tsiakopoulos, E., Poulakis, N., Fountzilas, George
Publikováno v:
American Journal of Clinical Oncology: Cancer Clinical Trials
This trial was conducted by the Hellenic Cooperative Oncology Group to improve the responses and survival in small cell lung cancer with a good prognosis, using a weekly intensive chemotherapy with alternated non-cross-resistant myelosuppressive agen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76b0273e3cb1a0217971addd98bb04a5
https://gnosis.library.ucy.ac.cy/handle/7/41728
https://gnosis.library.ucy.ac.cy/handle/7/41728
Autor:
Skarlos, Dimosthenis V., Samantas, E., Kosmidis, Paraskevas A., Fountzilas, George, Angelidou, M., Palamidas, P., Mylonakis, N., Provata, A., Papadakis, E., Klouvas, G. D., Theocharis, D., Panoussaki, E., Boleti, E., Sphakianoudis, G., Pavlidis, Nicholas
Publikováno v:
Annals of Oncology
Purpose: To compare the efficacy and toxicity of etoposide and cisplatin (EP) with etoposide and carboplatin (EC) in combination with irradiation in small-cell lung cancer (SCLC). Methods: Previously untreated patients (pts) with SCLC and measurable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4485::3a508ac42e100d426c7e779f01db041d
https://gnosis.library.ucy.ac.cy/handle/7/41723
https://gnosis.library.ucy.ac.cy/handle/7/41723
Autor:
N. Pavlidis, P. Kosmidis, M. Milonakis, E. Kosmas, M. Agelidou, F. Palamidas, G. Klouvas, A. Panoussaki, Epaminontas Samantas, E. Papadakis, E. Boleli, G. Foutzilas, D.V. Skarios, T h Vardoulakis, N. Kiamouris
Publikováno v:
European Journal of Cancer. 31:S22-S23
Between 2/88 and 5/91, 143 patients (pts) with SCLC (82 extensive and 61 limited disease) were randomized to receive Cisplatin and Etoposide (PE) or Carboplatin and Etoposide (CE). Responders, received concurrently with the 3rd cycle of chemotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5334ea567f65102ddb0888524312677e
https://doi.org/10.1016/0959-8049(95)95352-7
https://doi.org/10.1016/0959-8049(95)95352-7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Antonadou, Dosia, Coliarakis, Nikos, Synodinou, Maria, Athanassiou, Helen, Kouveli, Athina, Verigos, Cosmas, Georgakopoulos, Grigoris, Panoussaki, Katerina, Karageorgis, Pantelis, Throuvalas, Nicolas
Publikováno v:
International Journal of Radiation, Oncology, Biology, Physics; November 2001, Vol. 51 Issue: 4 p915-922, 8p